(1)
Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria. LMJHCR 2025, 3 (2), 1-11. https://doi.org/10.61919/xrpzj971.